CareRx Corp shares are on the rise, reflecting investor confidence as the company continues to show solid performance metrics.
In the latest trading session, CareRx Corp (CRRX.TO) saw its stock price increase by 2.59%, closing at CA$3.57. This uptick comes amidst steady financial performance and a growing market presence, making it a noteworthy player in the healthcare sector.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeMarket cap
$214.45M
P/E
7.9x
52W high
$3.95
52W low
$2.64
1W change
-2.90%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 53.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+53.5% Upside
Current Price
C$3.35
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
21.2%
Annualized
90-Day Vol
26.3%
Annualized
Trend (90d)
-42.9%
Annualized drift
90d Mean
C$2.87
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$3.18 | C$2.96 โ C$3.42 |
| 60 trading days | C$3.02 | C$2.73 โ C$3.35 |
| 90 trading days | C$2.87 | C$2.53 โ C$3.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a P/E ratio of 8.093 and a market cap of CA$220.8 million, CareRx Corp is positioned as an attractive investment option, especially for those looking for value in the healthcare space.
CareRx Corp's Stock Climbs 2.59% in One Day
The stock's rise reflects growing investor confidence in CareRx's operational strategy and financial health.
Bull case
CareRx's consistent financial performance, marked by increased Adjusted EBITDA and manageable net debt, suggests a strong foundation that could lead to further growth and profitability.
Bear case
Despite the positive movement, investors should stay cautious about potential market volatility and how broader economic conditions might impact the healthcare sector.
Positive Financial Metrics
CareRx Corp has reported strong financial metrics, including a profit margin of 7.23% and a dividend yield of 1.72%. These figures indicate healthy operational performance, likely contributing to the stock's upward movement.
Market Position and Growth Potential
With a market cap of CA$220.8 million, CareRx is well-positioned within the healthcare sector. The company's focus on providing specialized pharmacy services to long-term care facilities suggests a sustainable growth trajectory, making it an attractive option for investors.
Advertisement
